Oramed Pharmaceuticals Inc (ORMP)

[Amatuer17]

Heard the Barclays presentation - unfortunately it was last presentation so no Q&A.

The CEO reiterated 3 key milestones for 2022

——-
Oral insulin -
P3 trial 1
- the 100% enrollment next month - by mid April
- top line results will be announced in Q4-2022

P3 trial 2
- enrollment to be completed - Q4-2022

Oral Covid - the P2 results will come out in Q2-2022

NASH - P2 trial
12 week trial P2 results will be out in Q3-2022
——-

I am not expecting much from Covid trial as it does not have much importance.

So Q3 and Q4 are key. The P3 top line data is the key event and can make or kill the company